Janssen seeks USFDA nod for Darzalex to treat ASCT multiple myeloma
Drug Discovery | News | 0 Comment | 14 Mar, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics Licen...Read more
FDA approves new nasal spray for treatment-resistant depression
Drug Discovery | News | 0 Comment | 06 Mar, 2019
The U.S. Food and Drug Administration has approved Spravato (esketamine) nasal spray, in conjunction with an oral antide...Read more
Glenmark announces presentation of New Subtype Analysis of GBR 830
Drug Discovery | News | 0 Comment | 04 Mar, 2019
Glenmark Pharmaceuticals has announced the presentation of a new post hoc analysis of data from a Phase 2a, proof-of-con...Read more
USFDA accepts Merck and Pfizer’s sBLA for Renal Cancer drug
Drug Discovery | News | 0 Comment | 12 Feb, 2019
Merck and Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has accepted for Priority Review...Read more
Teva announces US launch of Vigabatrin
Drug Discovery | News | 0 Comment | 08 Feb, 2019
Teva Pharmaceutical Industries has announced the launch of a generic version of Sabril®1 (vigabatrin) tablets, ...Read more
Perrigo to launch its AB rated generic Zovirax cream
Drug Discovery | News | 0 Comment | 07 Feb, 2019
Perrigo Company plc has announced it has received final approval from the U.S. Food and Drug Administration for its AB r...Read more
BioLineRx gets Orphan Drug Designation for its pancreatic cancer drug
Drug Discovery | News | 0 Comment | 07 Feb, 2019
BioLineRx Ltd., an Israeli clinical-stage biopharmaceutical company focused on oncology, announced that the U.S. Food an...Read more
Reaction Biology Corporation buys ProQinase GmbH
Drug Discovery | News | 1 Comment | 05 Feb, 2019
Reaction Biology Corporation ("RBC") and ChinaEquity Group ("CEG") have announced the conclusion of a stock exchange tra...Read more
I-Mab, BCT to work on Arginine Depletion Therapy and Biomarker Study
Drug Discovery | News | 0 Comment | 04 Feb, 2019
I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the developm...Read more
FDA expands Lilly's ALIMTA Label
Drug Discovery | News | 0 Comment | 01 Feb, 2019
Eli Lilly and Companyhas announced that USFDA has granted approval for a new indication for ALIMTA® (pemetrexed...Read more
Neurocrine Biosciences collaborates with Voyager Therapeutics
Drug Discovery | News | 0 Comment | 31 Jan, 2019
Neurocrine Biosciences and Voyager Therapeutics has announced the formation of a strategic collaboration focused on the ...Read more
Pfizer and Lilly announce top-line results of Tanezumab
Drug Discovery | News | 0 Comment | 31 Jan, 2019
Pfizer and Eli Lilly have announced positive top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg i...Read more
J&J announces USFDA approval of IMBRUVICA
Drug Discovery | News | 0 Comment | 29 Jan, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) ...Read more
Basilea announces collaboration with Roche
Drug Discovery | News | 0 Comment | 25 Jan, 2019
Commercial stage biopharma company, Basilea Pharmaceutica has announced that it entered into a collaboration with Roche ...Read more
Wren Therapeutics completes £18M Series A Financing
Drug Discovery | News | 0 Comment | 23 Jan, 2019
UK based biopharma company, Wren Therapeutics focused on drug discovery and development for protein misfolding diseases ...Read more
AbbVie provides update on Phase 3 Study of IMBRUVICA
Drug Discovery | News | 0 Comment | 22 Jan, 2019
AbbVie, a research-based global biopharmaceutical company has announced an update on the Phase 3 RESOLVE trial (PCYC-113...Read more
Everest Medicines signs new deal targeting drug resistance
Drug Discovery | News | 0 Comment | 14 Jan, 2019
Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and ...Read more
Janssen submits application to EMA seeking approval of STELARA
Drug Discovery | News | 0 Comment | 11 Jan, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Group Type II Variation ...Read more